2025 at a Glance: Celebrating a Year of Peptide & Oligo CDMO Progress
December 17, 2025
As 2025 draws to a close, we want to extend our heartfelt thanks to our partners and colleagues around the world! Your trust and collaboration helped CPC Scientific advance our scientific capabilities, operational scale, and global footprint throughout the year.
Looking back on CPC Scientific’s year, one core theme stands out: when our people, partners, and platforms move in the same direction, together we can turn complex science into reliable, scalable solutions for life-saving medicines.
Discover the key milestones and highlights that shaped 2025 for CPC Scientific.
Global Business Milestone: Our Group’s Hong Kong IPO
In June 2025, our parent company Medtide Inc. was listed on the main board of the Hong Kong Stock Exchange! This milestone reflects not only our sustained growth, but also the global impact and technical excellence underpinning our group’s 25-year journey. Medtide’s IPO marks an exciting new chapter, focused on expanding our capacity to further support global peptide and oligo programs at scale.
Growing Library of Thought Leadership & CDMO Insights
In 2025, we expanded our Knowledge Center with new technical content, designed for partners and teams navigating the rapidly evolving peptide and oligo landscape. Our experts covered topics such as:
- GMP quality and scale-up frameworks across TIDES manufacturing
- Strategic value of partnering with specialized CDMOs, amid rise of GLP-1 and generic API pipelines
- Greener manufacturing strategies across large-scale SPPS and peptide macrocyclization
- Next-generation frontiers of RNA therapeutics and peptide–oligonucleotide conjugates
These resources reflect our commitment to bridging scientific excellence with thought leadership and practical manufacturing expertise. As a pioneering peptide and oligo CDMO, we share our industry insights to support the biopharma community in unpacking complex CMC challenges from discovery through commercialization.
Swipe through some of our featured 2025 resources below, or explore our White Papers and Articles.
In 2025, we expanded our Knowledge Center with new technical resources, designed for teams and partners navigating the rapidly evolving peptide and oligo landscape.
As a pioneering peptide and oligo CDMO, we share our thought leadership and industry insights to support the biopharma community in unpacking complex CMC challenges from discovery through commercialization.
Swipe through some of our featured 2025 resources below, or explore our White Papers and Articles.
Peptide & Oligo CDMO Leadership at Global Events
Throughout 2025, our teams connected with partners and delivered cutting-edge technical presentations at major industry meetings worldwide, including CPHI Frankfurt, TIDES USA, DCAT Week, NextGen Biomed, and more.
These touchpoints reinforced our position as a trusted CDMO driving thought leadership across the industry. Most importantly, they allowed us to strengthen the client and CDMO partnerships that translate innovation into impact for patients worldwide. To learn more, swipe through our featured event coverage and video presentations from 2025.
Expanding U.S. Peptide Manufacturing Capacity
Steady progress continued at our peptide API facility in Rocklin, California. This U.S. manufacturing capacity expansion reflects CPC Scientific’s long-term commitment to providing biopharma innovators with a reliable, global API supply chain and our world-class GMP peptide manufacturing capabilities.
Watch our latest construction update video for a behind-the-scenes snapshot of what’s ahead.
Looking Ahead to 2026: 25 Years of CDMO Excellence
2026 marks the 25th anniversary of our group! Entering this landmark year, CPC Scientific remains focused on advancing the scientific partnerships, global innovation, and unwavering commitment to quality that has defined our legacy for decades, as we continue supporting our clients through the most critical stages of drug development.
To our colleagues, clients, and collaborators: thank you for being part of this journey with us! We look forward to building the next chapter of peptide and oligo CDMO leadership together, in 2026 and beyond.
Ready to join a team where innovation meets global impact?
Learn more about careers at CPC Scientific and explore how you can help shape the future of pharmaceutical therapeutics.
Latest News & Resources
Catch the key moments from CPC Scientific's 2025 annual gathering! Our CEO Shawn Lee, PhD kicked off the meeting by providing valuable insights into the company's progress, highlighting our recent achievements, and sharing exciting developments on the horizon...
CPC Scientific at DCAT 2025! It was fantastic to meet with colleagues, clients, and friends, and showcase our cutting-edge capabilities in synthetic API development and commercial production. A huge thank you to everyone who joined us at the event and at the DCAT dinner!
We recently caught up with Chief Solutions Officer Baosheng Liu, PhD to discuss how CPC Scientific is shaping the future of peptide and oligo manufacturing, and how the CDMO industry is evolving in the next decade...
CPC Scientific is back at Boulder Peptide Symposium 2025 as a Gold Sponsor! Discover key moments from the symposium and see how our team is pioneering innovations in large-scale peptide synthesis...
CPC Scientific is thrilled to return to CPHI Frankfurt 2025! Explore our booth as we recap key moments from Day 1 of CPHI, where we're highlighting our position as a globally pioneering peptide & oligo CDMO...
President Theresa Cheng spoke to PhD students at Weill Cornell Graduate School, sharing industry insights and exploring how academic research today can translate into tomorrow’s cutting-edge healthcare leadership...
Catch the key moments from CPC Scientific's 2025 annual gathering! Our CEO Shawn Lee, PhD kicked off the meeting by providing valuable insights into the company's progress, highlighting our recent achievements, and sharing exciting developments on the horizon...
CPC Scientific at DCAT 2025! It was fantastic to meet with colleagues, clients, and friends, and showcase our cutting-edge capabilities in synthetic API development and commercial production. A huge thank you to everyone who joined us at the event and at the DCAT dinner!
We recently caught up with Chief Solutions Officer Baosheng Liu, PhD to discuss how CPC Scientific is shaping the future of peptide and oligo manufacturing, and how the CDMO industry is evolving in the next decade...
CPC Scientific is back at Boulder Peptide Symposium 2025 as a Gold Sponsor! Discover key moments from the symposium and see how our team is pioneering innovations in large-scale peptide synthesis...
CPC Scientific is thrilled to return to CPHI Frankfurt 2025! Explore our booth as we recap key moments from Day 1 of CPHI, where we're highlighting our position as a globally pioneering peptide & oligo CDMO...
President Theresa Cheng spoke to PhD students at Weill Cornell Graduate School, sharing industry insights and exploring how academic research today can translate into tomorrow’s cutting-edge healthcare leadership...